It works on GLP-1, GIP, and glucagon receptors at the same time
This allows appetite regulation and metabolic patterns to adjust gradually rather than experiencing the sudden rebound that comes with cold-turkey cessation
Treatment with Semaglutide (weekly dosing) has been found to reduce overeating behavior, food cravings, and preference for high-fat, high-calorie foods
These drugs mimic the effects of the naturally occurring GLP-1 hormone, which is produced in the small intestine and plays a crucial role in regulating insulin secretion, glucose homeostasis, and appetite
Most side effects resolve with dose optimization
They work within 5 to 15 minutes